§ 780-113.8. Drug overdose medication
Purdon's Pennsylvania Statutes and Consolidated StatutesTitle 35 P.S. Health and SafetyEffective: January 3, 2023
Effective: January 3, 2023
35 P.S. § 780-113.8
§ 780-113.8. Drug overdose medication
(a) The department, in carrying out its duties under 28 Pa. Code Ch. 1023 (relating to personnel),1 shall have the following duties:
(3) In consultation with the Department of Drug and Alcohol Programs, develop or approve training and instructional materials about recognizing opioid-related overdoses, administering an opioid antagonist and promptly seeking medical attention. The training and instruction materials shall be provided free of charge on the Internet.
(2) Authorize a law enforcement officer or firefighter who has completed training under subsection (a)(2), or who has received the training and instructional materials under subsection (a)(3), to administer an opioid antagonist to an individual undergoing or believed to be undergoing an opioid-related drug overdose.
(c) Notwithstanding any other law to the contrary, a health care professional otherwise authorized to prescribe an opioid antagonist may dispense, prescribe or distribute the opioid antagonist directly or by a standing order to an authorized law enforcement officer or firefighter in accordance with an agreement under subsection (b) or to a person at risk of experiencing an opioid-related overdose or family member, friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose.
(d) The provisions of the act of September 27, 1961 (P.L. 1700, No. 699),2 known as the “Pharmacy Act,” shall not apply to a law enforcement officer or firefighter who stores an opioid antagonist pursuant to an agreement under subsection (b), and in accordance with directions from the health care professional that prescribed, dispensed or distributed the opioid antagonist, or to a person or organization acting at the direction of a health care professional authorized to prescribe an opioid antagonist so long as such activities are undertaken without charge or compensation.
(h) As used in this section, the term “opioid antagonist” means a drug or device approved by the Federal Food, Drug, and Cosmetic Act (52 Stat. 1040, 21 U.S.C. § 301 et seq.) for emergency reversal of known or suspected opioid overdose, including naloxone hydrochloride or other similarly acting drugs approved by the United States Food and Drug Administration for the treatment of an opioid overdose.
Credits
1972, April 14, P.L. 233, No. 64, § 13.8, added 2014, Sept. 30, P.L. 2487, No. 139, § 1, effective in 60 days [Dec. 1, 2014]. Amended 2022, Nov. 3, P.L. 1984, No. 135, § 1, effective in 60 days [Jan. 3, 2023].
35 P.S. § 780-113.8, PA ST 35 P.S. § 780-113.8
Current through Act 10 of the 2024 Regular Session. Some statute sections may be more current, see credits for details.
End of Document |